Axonal-Biostatem becomes Heva logo

Axonal-Biostatem becomes Heva

Axonal-Biostatem becomes Heva, Docaposte subsidiary, and La Poste Santé & Autonomie brand

60 employees · est. 1989 · Nanterre, France

VS
OPIS  logo

OPIS

A Science Driven Biotech Focused CRO

258 employees · est. 1998 · Desio, Italy

Axonal-Biostatem becomes Heva is the older company (1989 vs 1998); OPIS is the larger of the two.

Side-by-Side Comparison

Axonal-Biostatem becomes Heva OPIS
Founded
1989 older 1998
Headquarters
Nanterre, France Desio, Italy
Employees
60 258 larger
Industry
Analytics, Biotechnology, Information Technology Pharmaceutical
Funding Stage
Not tracked yet Not tracked yet
Total Funding
Not tracked yet Not tracked yet
Funding Rounds
Not tracked yet Not tracked yet
Services
Not tracked yet Not tracked yet
Target Customers
Not tracked yet Not tracked yet
Taxonomy
Clinical Research, Health Data Processing, Clinical Trials Management, Pharmaceutical Industry Support, Medical Device Industry Support, Biotechnology Industry Support, Real World Evidence, Regulatory Submissions, Medical Writing Services, Post-Market Clinical Monitoring, SNDS (Système National Des Données De Santé) Integration, Early Access Programs, Agile Project Management, Healthcare Data Security, Medical And Scientific Expertise Clinical Research, CRO, Clinical Development, Early Phase Trials, Post Market Studies, Observational Research, Medical Device Clinical Investigations, Nutraceutical Studies, Medical Affairs, Regulatory, Pharmacovigilance, Statistical Analysis And Consultancy, Project Control
Website
axonalbiostatem.com opisresearch.com
Axonal-Biostatem becomes Heva logo

About Axonal-Biostatem becomes Heva

Axonal-Biostatem rebrands as Heva, a subsidiary of Docaposte and a brand of La Poste Santé & Autonomie. With over 30 years of experience, Heva specializes in processing health data for research in an ethical, secure, and sovereign framework. The company offers comprehensive services for clinical res...

OPIS  logo

About OPIS

OPIS is a science-driven biotech focused CRO that was founded in 1998 by medical doctors from the Pharma Industry. With 25 years of experience in a wide range of therapeutic areas, OPIS distinguishes itself as a global clinical CRO that provides full-service, 360° clinical trial support. This includ...

We will tell you when either one moves

BounceWatch watches Axonal-Biostatem becomes Heva and OPIS for new funding, fast hiring, new executives and a change of software vendor. When one happens, we email you the same day.

Watch both — free

Funding, hiring, leadership and stack changes at Axonal-Biostatem becom... and OPIS — by email.

Frequently Asked Questions

Axonal-Biostatem becomes Heva — Axonal-Biostatem becomes Heva, Docaposte subsidiary, and La Poste Santé & Autonomie brand. OPIS — A Science Driven Biotech Focused CRO. Both companies operate in related markets but may differ in funding stage, team size, and product focus.
Axonal-Biostatem becomes Heva and OPIS operate in overlapping markets and are frequently compared. Track both companies on Bounce Watch to monitor their growth signals in real time.

Compare Axonal-Biostatem becomes Heva with someone else

Start typing a company name or domain.

Compiled from the BounceWatch company index. We last looked at Axonal-Biostatem becomes Heva on 13 Sep 2024, and OPIS on 14 Nov 2024. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.

One analytics cookie (Google Analytics). Cookie Policy

Book a demo 30 minutes